Phio Pharmaceuticals
PHIO
8 hedge funds and large institutions have $1.25M invested in Phio Pharmaceuticals in 2020 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 2 closing their positions.
100% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 2
100% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 1
92% more capital invested
Capital invested by funds: $647K → $1.25M (+$598K)
14% more funds holding
Funds holding: 7 → 8 (+1)
0.23% more ownership
Funds ownership: 0% → 0.23% (+0.23%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CH
CVI Holdings
Wilmington,
Delaware
|
+$2.05M |
| 2 |
SM
Sabby Management
Miami Beach,
Florida
|
+$1.46M |
| 3 |
Renaissance Technologies
New York
|
+$200K |
| 4 |
JP Morgan Chase
New York
|
+$124K |
| 5 |
EDRH
Edmond de Rothschild Holding
Chambesy,
Switzerland
|
+$71.5K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SG Americas Securities
New York
|
-$135K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$5K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$1.85K |
| 4 |
KFS
Kelly Financial Services
Braintree,
Massachusetts
|
-$1 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
CH
1
CVI Holdings
Wilmington,
Delaware
| $637K | +$2.05M | +3,334 | New |
|
|
SM
2
Sabby Management
Miami Beach,
Florida
| $452K | +$1.46M | +2,363 | New |
|
|
3
Renaissance Technologies
New York
| $73K | +$200K | +325 | +580% |
|
|
4
JP Morgan Chase
New York
| $38K | +$124K | +201 | New |
|
5
HSBC Holdings
London,
United Kingdom
| $22K | +$67.8K | +110 | +2,200% |
|
|
EDRH
6
Edmond de Rothschild Holding
Chambesy,
Switzerland
| $22K | +$71.5K | +116 | New |
|
|
7
UBS Group
Zurich,
Switzerland
| $1K | -$1.85K | -3 | -38% |
|
|
8
SG Americas Securities
New York
| – | -$135K | -133 | Closed |
|
|
9
Vanguard Group
Malvern,
Pennsylvania
| – | -$5K | -4 | Closed |
|
|
KFS
10
Kelly Financial Services
Braintree,
Massachusetts
| – | -$1 | – | – |
|
PHIO Hedge Fund Activity: Q1 2020 in Review
8 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in Phio Pharmaceuticals (PHIO) for Q1 2020, worth a combined $1.25M — up 92% from $647K a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new PHIO positions and 2 closed out — a net gain of 2 holders — while 2 added to existing stakes and 1 trimmed.
The largest buyer was CVI Holdings, opening a new position worth an estimated $2.05M. The largest seller was SG Americas Securities, exiting entirely with an estimated $135K sold.
- 8 institutional investors held Phio Pharmaceuticals (PHIO) as of Q1 2020, up from 7 in Q4 2019.
- Funds reported $1.25M of Phio Pharmaceuticals stock for Q1 2020, up 92% quarter-over-quarter.
- 4 funds opened new Phio Pharmaceuticals positions in Q1 2020 and 2 closed out, a net change of +2 holders.
- The largest Phio Pharmaceuticals buyer in Q1 2020 was CVI Holdings, an estimated $2.05M added.
- The largest Phio Pharmaceuticals seller in Q1 2020 was SG Americas Securities, an estimated $135K sold.
Based on aggregated 13F filings for Q1 2020.